Serological response to influenza vaccination among children vaccinated for multiple influenza seasons

Sajjad Rafiq1, Margaret L Russell, Richard Webby

  • 1Department of Pathology, McMaster University, Hamilton, Ontario, Canada.

Plos One
|December 15, 2012
PubMed

Insights

Multiple influenza vaccinations in children aged 3-15 years did not significantly alter seroprotection proportions. This study found consistent protection levels regardless of the number of seasonal trivalent inactivated influenza vaccine (TIV) doses received.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Vaccinology

Background:

  • Influenza vaccination is crucial for child health.
  • Understanding the impact of multiple seasonal vaccinations on immune response is important.
  • Previous studies have not fully elucidated the long-term seroprotection effects in children.

Purpose of the Study:

  • To evaluate if multiple seasons of influenza vaccination affect seroprotection proportions in children aged 3 to 15 years.
  • To compare seroprotection rates against different influenza strains based on vaccination history.

Main Methods:

  • A cohort of 131 healthy children (3-15 years) received trivalent inactivated influenza vaccine (TIV) for one, two, or three consecutive seasons (2005-2008).
  • Antibody titers were measured using hemagglutination inhibition (HAI) assays against A/H1N1, A/H3N2, and B/Malaysia strains.
  • Seroprotection proportions were analyzed using cut-points of 1:40 and 1:320, comparing outcomes based on the number of vaccination seasons.

Main Results:

  • High seroprotection (>85%) was observed against A/H1N1 and A/H3N2 strains, irrespective of the number of TIV seasons or seroprotection cut-point used.
  • For the B/Malaysia strain, seroprotection proportions did not change with the number of vaccination seasons.
  • Lower seroprotection rates were noted for the B strain compared to A strains, and a higher cut-point (1:320) resulted in lower seroprotection than the 1:40 cut-point.

Conclusions:

  • The proportion of children achieving seroprotection against influenza is not significantly affected by the number of vaccination seasons.
  • While protection against influenza A strains remained high, the B strain showed lower and more variable seroprotection.
  • These findings suggest that while annual vaccination is important, increasing the number of seasons vaccinated does not necessarily enhance seroprotection levels in children.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...